PEAK6 Investments LLC - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 18 filers reported holding SEATTLE GENETICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
PEAK6 Investments LLC ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q3 2020$17,573,000
+163.7%
89,800
+129.0%
0.04%
+87.0%
Q2 2020$6,664,000
+32.8%
39,219
-9.9%
0.02%
-23.3%
Q1 2020$5,019,000
-32.7%
43,506
-50.2%
0.03%
-36.2%
Q3 2019$7,457,000
-17.0%
87,320
-32.7%
0.05%
-21.7%
Q2 2019$8,986,000
+18.6%
129,835
+25.5%
0.06%
+36.4%
Q1 2019$7,577,000
-3.3%
103,451
-25.2%
0.04%
-12.0%
Q4 2018$7,839,000
+281.6%
138,355
+419.5%
0.05%
+525.0%
Q3 2018$2,054,00026,6340.01%
Other shareholders
SEATTLE GENETICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Lagoda Investment Management, L.P. 57,170$10,013,0005.39%
Boxer Capital, LLC 400,000$70,056,0002.25%
PARTNERS CAPITAL INVESTMENT GROUP, LLP 110,153$19,292,0001.10%
DCF Advisers, LLC 13,300$2,329,0000.96%
XTX MARKETS LLC 2,418$423,0000.87%
FAIRFIELD, BUSH & CO. 15,035$2,633,0000.77%
Parcion Private Wealth LLC 4,520$792,0000.10%
Gulf International Bank (UK) Ltd 26,091$4,569,0000.06%
Princeton Portfolio Strategies Group LLC 1,500$263,0000.05%
Redpoint Investment Management Pty Ltd 2,392$419,0000.04%
View complete list of SEATTLE GENETICS INC shareholders